New Jersey A 3917: Requires pharmaceutical manufacturers and wholesale distributors to annually report certain manufacturing and dispensing information concerning prescription opioid drugs, medication-assisted treatment drugs, and opioid antidote drugs.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-05-07)

State: New Jersey · Session: 218 · Bill: A 3917

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Calabrese, Clinton, Murphy, Carol A., Sumter, Shavonda E.

View New Jersey A 3917 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.